Mesa Laboratories, Inc. (MLAB): Price and Financial Metrics

Mesa Laboratories, Inc. (MLAB): $264.24

0.89 (+0.34%)

POWR Rating

Component Grades














  • Quality is the dimension where MLAB ranks best; there it ranks ahead of 82.32% of US stocks.
  • MLAB's strongest trending metric is Stability; it's been moving up over the last 31 weeks.
  • MLAB's current lowest rank is in the Sentiment metric (where it is better than 3.95% of US stocks).

MLAB Stock Summary

  • MLAB's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 2,611.6 -- higher than 98.22% of US-listed equities with positive expected earnings growth.
  • MLAB's current price/earnings ratio is 406.19, which is higher than 97.99% of US stocks with positive earnings.
  • In terms of volatility of its share price, MLAB is more volatile than only 5.3% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Mesa Laboratories Inc are TRNS, PCTI, KBR, OR, and XYL.
  • Visit MLAB's SEC page to see the company's official filings. To visit the company's web site, go to

MLAB Price Target

For more insight on analysts targets of MLAB, see our MLAB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $273.00 Average Broker Recommendation 1.8 (Moderate Buy)

MLAB Stock Price Chart Interactive Chart >

Price chart for MLAB

MLAB Price/Volume Stats

Current price $264.24 52-week high $307.97
Prev. close $263.35 52-week low $207.54
Day low $261.31 Volume 16,600
Day high $265.00 Avg. volume 25,298
50-day MA $250.78 Dividend yield 0.24%
200-day MA $265.30 Market Cap 1.36B

Mesa Laboratories, Inc. (MLAB) Company Bio

Mesa Laboratories, Inc. designs, manufactures, and markets quality control instruments and disposable products. It operates through three segments: Instruments, Biological Indicators, and Continuous Monitoring. The company was founded in 1982 and is based in Lakewood, Colorado.

MLAB Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$264.24$100.19 -59%

Below please find a table outlining a discounted cash flow forecast for MLAB, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Mesa Laboratories Inc ranked in the 31th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 59%. As for the metrics that stood out in our discounted cash flow analysis of Mesa Laboratories Inc, consider:

  • Mesa Laboratories Inc's effective tax rate, as measured by taxes paid relative to net income, is at 0 -- greater than only 0% of US stocks with positive free cash flow.
  • The weighted average cost of capital for the company is 10. This value is greater than 77.58% stocks in the Technology sector that generate free cash flow.

Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price

DSGX, AYX, BKI, BLKB, and FIVN can be thought of as valuation peers to MLAB, in the sense that they are in the Technology sector and have a similar price forecast based on DCF valuation.

MLAB Latest News Stream

Event/Time News Detail
Loading, please wait...

MLAB Latest Social Stream

Loading social stream, please wait...

View Full MLAB Social Stream

Latest MLAB News From Around the Web

Below are the latest news stories about Mesa Laboratories Inc that investors may wish to consider to help them evaluate MLAB as an investment opportunity.

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

LAKEWOOD, Colo., June 01, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q21”) and full year ended March 31, 2021 (“FY21”). Financial highlights for the quarter and year ended March 31, 2021 as compared to last year: Revenues increased 11% and 14%, respectivelyOperating income increased 318% and 56%, respectively Non-GAAP adjusted operating income1 excluding unusual items increased 14% and 12%, respectively Financial Results (amounts in thousands, except per share data) In comparison to the same quarter in the prior year, 4Q21 revenues increased 11% to $37,964, operating income increased 318% to $4,296 and net income was $3,920, an increase of 353% or $0.74 per diluted share of common stock. As detailed in the Unusual Ite...

Yahoo | June 1, 2021

Mesa Labs (MLAB) to Report Q4 Results: Wall Street Expects Earnings Growth

Mesa Labs (MLAB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | May 31, 2021

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Expensive For A Reason? A Look At Its Intrinsic Value

In this article we are going to estimate the intrinsic value of Mesa Laboratories, Inc. ( NASDAQ:MLAB ) by taking the...

Yahoo | May 24, 2021

7 Small-Cap Stocks To Buy for Their Big Ambitions

These seven small-cap stocks have the potential of rebounding and making it big in the post-pandemic reality of 2021.

Muslim Farooque on InvestorPlace | May 10, 2021

There Are Reasons To Feel Uneasy About Mesa Laboratories' (NASDAQ:MLAB) Returns On Capital

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

Yahoo | April 9, 2021

Read More 'MLAB' Stories Here

MLAB Price Returns

1-mo 6.92%
3-mo -0.71%
6-mo -4.68%
1-year 17.69%
3-year 33.85%
5-year 121.01%
YTD -7.70%
2020 15.22%
2019 20.01%
2018 68.27%
2017 1.74%
2016 24.12%

MLAB Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MLAB Dividend History

Continue Researching MLAB

Here are a few links from around the web to help you further your research on Mesa Laboratories Inc's stock as an investment opportunity:

Mesa Laboratories Inc (MLAB) Stock Price | Nasdaq
Mesa Laboratories Inc (MLAB) Stock Quote, History and News - Yahoo Finance
Mesa Laboratories Inc (MLAB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8639 seconds.